000144006 001__ 144006
000144006 005__ 20240229112614.0
000144006 0247_ $$2doi$$a10.3390/cancers11060822
000144006 0247_ $$2pmid$$apmid:31200555
000144006 037__ $$aDKFZ-2019-01557
000144006 041__ $$aeng
000144006 082__ $$a610
000144006 1001_ $$0P:(DE-He78)fd6c999735493ab2e8a00a80fc47527d$$aSchulze-Edinghausen, Lena$$b0$$eFirst author$$udkfz
000144006 245__ $$aDissecting the Prognostic Significance and Functional Role of Progranulin in Chronic Lymphocytic Leukemia.
000144006 260__ $$aBasel$$bMDPI$$c2019
000144006 3367_ $$2DRIVER$$aarticle
000144006 3367_ $$2DataCite$$aOutput Types/Journal article
000144006 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1681387646_19512
000144006 3367_ $$2BibTeX$$aARTICLE
000144006 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000144006 3367_ $$00$$2EndNote$$aJournal Article
000144006 520__ $$aChronic lymphocytic leukemia (CLL) is known for its strong dependency on the tumor microenvironment. We found progranulin (GRN), a protein that has been linked to inflammation and cancer, to be upregulated in the serum of CLL patients compared to healthy controls, and increased GRN levels to be associated with an increased hazard for disease progression and death. This raised the question of whether GRN is a functional driver of CLL. We observed that recombinant GRN did not directly affect viability, activation, or proliferation of primary CLL cells in vitro. However, GRN secretion was induced in co-cultures of CLL cells with stromal cells that enhanced CLL cell survival. Gene expression profiling and protein analyses revealed that primary mesenchymal stromal cells (MSCs) in co-culture with CLL cells acquire a cancer-associated fibroblast-like phenotype. Despite its upregulation in the co-cultures, GRN treatment of MSCs did not mimic this effect. To test the relevance of GRN for CLL in vivo, we made use of the Eμ-TCL1 CLL mouse model. As we detected strong GRN expression in myeloid cells, we performed adoptive transfer of Eμ-TCL1 leukemia cells to bone marrow chimeric Grn-/- mice that lack GRN in hematopoietic cells. Thereby, we observed that CLL-like disease developed comparable in Grn-/- chimeras and respective control mice. In conclusion, serum GRN is found to be strongly upregulated in CLL, which indicates potential use as a prognostic marker, but there is no evidence that elevated GRN functionally drives the disease.
000144006 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0
000144006 588__ $$aDataset connected to CrossRef, PubMed,
000144006 7001_ $$0P:(DE-HGF)0$$aDürr, Claudia$$b1
000144006 7001_ $$0P:(DE-He78)c3e32dca3eea6c46d4d140757aaf6e18$$aÖztürk, Selcen$$b2$$udkfz
000144006 7001_ $$aZucknick, Manuela$$b3
000144006 7001_ $$0P:(DE-He78)e15dfa1260625c69d6690a197392a994$$aBenner, Axel$$b4$$udkfz
000144006 7001_ $$0P:(DE-He78)ece9c40a97e047bf607a89f04fcc7466$$aKalter, Verena$$b5$$udkfz
000144006 7001_ $$0P:(DE-He78)5ad7de84a84805746cf4d7f7f90cdbff$$aOhl, Sibylle$$b6$$udkfz
000144006 7001_ $$0P:(DE-HGF)0$$aClose, Viola$$b7
000144006 7001_ $$aWuchter, Patrick$$b8
000144006 7001_ $$aStilgenbauer, Stephan$$b9
000144006 7001_ $$0P:(DE-He78)e13b4363c5fe858044ef8a39c02c870c$$aLichter, Peter$$b10$$udkfz
000144006 7001_ $$0P:(DE-He78)e67f907703fcb2cf909f4d72d50268b5$$aSeiffert, Martina$$b11$$eLast author$$udkfz
000144006 773__ $$0PERI:(DE-600)2527080-1$$a10.3390/cancers11060822$$gVol. 11, no. 6, p. 822 -$$n6$$p822$$tCancers$$v11$$x2072-6694$$y2019
000144006 909CO $$ooai:inrepo02.dkfz.de:144006$$pVDB
000144006 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)fd6c999735493ab2e8a00a80fc47527d$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000144006 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000144006 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c3e32dca3eea6c46d4d140757aaf6e18$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000144006 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e15dfa1260625c69d6690a197392a994$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000144006 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)ece9c40a97e047bf607a89f04fcc7466$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000144006 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)5ad7de84a84805746cf4d7f7f90cdbff$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000144006 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000144006 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e13b4363c5fe858044ef8a39c02c870c$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000144006 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e67f907703fcb2cf909f4d72d50268b5$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000144006 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000144006 9141_ $$y2019
000144006 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCERS : 2017
000144006 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000144006 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000144006 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000144006 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000144006 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000144006 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000144006 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review
000144006 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000144006 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000144006 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000144006 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000144006 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000144006 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000144006 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000144006 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCANCERS : 2017
000144006 9201_ $$0I:(DE-He78)B060-20160331$$kB060$$lB060 Molekulare Genetik$$x0
000144006 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lC060 Biostatistik$$x1
000144006 9201_ $$0I:(DE-He78)B061-20160331$$kB061$$lB061 Mechanismen der Leukämogenese$$x2
000144006 9201_ $$0I:(DE-He78)L101-20160331$$kL101$$lDKTK Heidelberg$$x3
000144006 980__ $$ajournal
000144006 980__ $$aVDB
000144006 980__ $$aI:(DE-He78)B060-20160331
000144006 980__ $$aI:(DE-He78)C060-20160331
000144006 980__ $$aI:(DE-He78)B061-20160331
000144006 980__ $$aI:(DE-He78)L101-20160331
000144006 980__ $$aUNRESTRICTED